B+
Bull case
20%
Probability
Target price
$2.88
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
INBX
Inhibrx BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive clinical readouts or a favorable partnership that improves funding can materially de‑risk the lead programs and drive a multi‑month re‑rating toward the bull target.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Adverse or inconclusive clinical data, partner delays, or the need for dilutive financing would push the stock toward the bear target as risk premia and liquidity pressures increase.
Momentum
95
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.92 · Bull $2.88 · Bear $1.15Analysis 2025-11-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-17 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $266.67
Why
Momentum95 · Δ7d +11.8
Value41 · Δ7d 0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Adverse or inconclusive clinical data, partner delays, or the need for dilutive financing would push the stock toward the bear target as risk premia and liquidity pressures increase.
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
2026-03-31
Clinical readouts for lead programs
Lead driver: Value · See fundamentals
Momentum
95
9% active weight
Current posture
7d trendImproving
Δ7d
+11.8
Δ21d
+71.2
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade F. Momentum 95.3 / Value 41.2 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-11-17. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$1.92
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
B-
Bear case
30%
Probability
Target price
$1.15
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.35B
Beta
-
Shares Out
14.72M
P/E (TTM) · Derived
-10.2
P/S (TTM)
798.66
P/FCF (TTM) · Derived
-10.86
Rev YoY
-100.0%
EPS YoY
+26.3%
Gross Margin
-80.4%
Op Margin
-11002.1%
Net Debt
-$17.21M
Current Ratio
5.07
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data